ArticleCancers2022

Clinical Utility of Liquid Biopsy to Detect BRAF and NRAS Mutations in Stage III/IV Melanoma Patients by Using Real-Time PCR.

Emilio Francesco Giunta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.